Study of SBP-101 in Pancreatic Cancer

NCT02657330 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer
Ductal Adenocarcinoma of the Pancreas

Interventions

DRUG: SBP-101

Sponsor

Panbela Therapeutics, Inc.